Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage
- 30 June 1995
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 109 (6) , 1164-1172
- https://doi.org/10.1016/s0022-5223(95)70200-8
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurementBlood Coagulation & Fibrinolysis, 1993
- Influence of human plasma kallikrein on lysosomal enzyme release from polymorphonuclear leukocytesInflammation Research, 1991
- F XIIAnnals of Hematology, 1990
- High-Dose Aprotinin: Hemostatic Effects in Open Heart OperationsThe Annals of Thoracic Surgery, 1989
- N-terminal amino acid sequences of three functionally different troponin T isoforms from rabbit fast skeletal muscleJournal of Molecular Biology, 1989
- Cardiac-specific troponin-l radioimmunoassay in the diagnosis of acute myocardial infarctionAmerican Heart Journal, 1987
- Aprotinin does not add protective effect to cold cardioplegia during coronary artery bypass surgeryScandinavian Journal of Thoracic and Cardiovascular Surgery, 1986
- Calcium binding to cardiac myocytes protected from proteolytic enzyme activityBiochimica et Biophysica Acta (BBA) - General Subjects, 1985
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985
- Effect of the kallikrein inhibitor aprotinin on myocardial ischemic injury after coronary occlusion in the dogThe American Journal of Cardiology, 1977